FOLD vs IAG Comparison

Amicus Therapeutics Inc is a biotechnology company focused on discovering, developing and delivering medicines for people living with rare metabolic diseases. The company is engaged in developing a pipeline of medicines for rare metabolic diseases, including a rare disease gene therapy portfolio. It has a portfolio of product opportunities, including oral precision medicine for people living with Fabry disease who have amenable genetic variants; a clinical-stage, treatment paradigm for Pompe disease, and a rare disease gene therapy portfolio. The company has one segment focused on the discovery, development, and commercialization of advanced therapies to treat a range of devastating rare and orphan diseases.

Iamgold Corp is a mid-tier gold mining company. The company operating gold mines are divided into geographic segments such as Burkina Faso - Essakane mine, Canada - Doyon division, including Westwood mine. The company's s non-gold mine segments are the Cote Gold project, Exploration and evaluation and development, and Corporate - which includes royalty interests. The company generates the majority of its revenue from the Burkina Faso segment.